XTL Biopharmaceuticals acquires 85% stake in NeuroNOS for autism therapeutics
Go back to XTL Biopharmaceuticals acquires 85% stake in NeuroNOS for autism therapeutics| (NASDAQ: XAIR) | Delayed: 5.21 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.21 | 52 Week High | $ | |||
| Open | $5.21 | 52 Week Low | $ | |||
| Day High | $5.21 | P/E | N/A | |||
| Day Low | $5.21 | EPS | $ | |||
| Volume | 117 | |||||
| XTL BIOPHARM SP ADR (NASDAQ: XTLB) | Delayed: 2.98 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.98 | 52 Week High | $1.75 | |||
| Open | $2.98 | 52 Week Low | $0.64 | |||
| Day High | $2.98 | P/E | N/A | |||
| Day Low | $2.98 | EPS | $0.00 | |||
| Volume | 44 | |||||
